Press releases

Reaching new heights

Reaching new heights

Neuron23 Closes $113.5 Million Series A and B Financing led by Westlake Village BioPartners, Klein

December 16, 2020 Biotechnology company launches to accelerate development of precision medicines for genetically defined neurological...

Case Study Origenis GmbH: With Small Molecules against Neurodegenerative Diseases

September 03, 2019 Mithilfe ihrer KI-basierten Small Molecules Technologie schafften es Michael Almstetter und seine zwei Mitstreiter...

Origenis GmbH Announces Research Collaboration with U.S. Cancer Center

June 04, 2019 Origenis AI Discovery Platform to Identify and Optimize Small Molecule Preclinical Development Candidates for Glioblastoma...